相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cancer statistics, 2022
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2022)
HNRNPA2B1 Demonstrates Diagnostic and Prognostic Values Based on Pan-Cancer Analyses
Chaoyang Chen et al.
COMPUTATIONAL AND MATHEMATICAL METHODS IN MEDICINE (2022)
Genetic Ancestry Contributes to Somatic Mutations in Lung Cancers from Admixed Latin American Populations
Jian Carrot-Zhang et al.
CANCER DISCOVERY (2021)
Encorafenib Plus Cetuximab as a New Standard of Care for Previously Treated BRAF V600E-Mutant Metastatic Colorectal Cancer: Updated Survival Results and Subgroup Analyses from the BEACON Study
Josep Tabernero et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
The Role of p53 Signaling in Colorectal Cancer
Magdalena C. Liebl et al.
CANCERS (2021)
PIK3CA mutation and clinicopathological features of colorectal cancer: a systematic review and Meta-Analysis
Juan Jin et al.
ACTA ONCOLOGICA (2020)
APC truncating mutations in Middle Eastern Population: Tankyrase inhibitor is an effective strategy to sensitize APC mutant CRC To 5-FU chemotherapy
Abdul K. Siraj et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
The heterogeneous clinical and pathological landscapes of metastatic Braf-mutated colorectal cancer
Giuseppe Nicolo Fanelli et al.
CANCER CELL INTERNATIONAL (2020)
HER2 as a Predictive Biomarker and Treatment Target in Colorectal Cancer
Astrid De Cuyper et al.
CLINICAL COLORECTAL CANCER (2020)
PIK3CA Gene Mutations in Solid Malignancies: Association with Clinicopathological Parameters and Prognosis
Ali Alqahtani et al.
CANCERS (2020)
Prognostic and Predictive Molecular Biomarkers for Colorectal Cancer: Updates and Challenges
Eric Koncina et al.
CANCERS (2020)
KRAS as a druggable target in NSCLC: Rising like a phoenix after decades of development failures
Alex Friedlaender et al.
CANCER TREATMENT REVIEWS (2020)
Prevalence of the BRAF p.v600e variant in patients with colorectal cancer from Mexico and its estimated frequency in Latin American and Caribbean populations
Jesus Arturo Hernandez-Sandoval et al.
JOURNAL OF INVESTIGATIVE MEDICINE (2020)
Prognostic value of KRAS mutation status in colorectal cancer patients: a population-based competing risk analysis
Dongjun Dai et al.
PEERJ (2020)
KRAS, NRAS, and BRAF mutation prevalence, clinicopathological association, and their application in a predictive model in Mexican patients with metastatic colorectal cancer: A retrospective cohort study
Hector Eduardo Sanchez-Ibarra et al.
PLOS ONE (2020)
Distinct Colorectal Cancer-Associated APC Mutations Dictate Response to Tankyrase Inhibition
Emma M. Schatoff et al.
CANCER DISCOVERY (2019)
High hnRNP AB expression is associated with poor prognosis in patients with colorectal cancer
Jun-Min Zhou et al.
ONCOLOGY LETTERS (2019)
Mutation profiling of cancer drivers in Brazilian colorectal cancer
Wellington dos Santos et al.
SCIENTIFIC REPORTS (2019)
HER2-targeted therapy: an emerging strategy in advanced colorectal cancer
Anna La Salvia et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2019)
KRAS and NRAS mutational gene profile of metastatic colorectal cancer patients in Jordan
Muhammad Awidi et al.
PLOS ONE (2019)
Association of genetic ancestry with colorectal tumor location in Puerto Rican Latinos
Julyann Perez-Mayoral et al.
HUMAN GENOMICS (2019)
Targeting HER2 in Colorectal Cancer: The Landscape of Amplification and Short Variant Mutations in ERBB2 and ERBB3
Jeffrey S. Ross et al.
CANCER (2018)
Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer
Katherine A. Hoadley et al.
CELL (2018)
Phenotypic and genotypic differences in colorectal carcinoma among Caucasians, Asians, and Hispanics lack statistical significance
Sara J. Hoffman et al.
PATHOLOGY RESEARCH AND PRACTICE (2018)
PIK3CA mutations confer resistance to first-line chemotherapy in colorectal cancer
Qiang Wang et al.
CELL DEATH & DISEASE (2018)
Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade
Dung T. Le et al.
SCIENCE (2017)
AACR Project GENIE: Powering Precision Medicine through an International Consortium
Fabrice Andre et al.
CANCER DISCOVERY (2017)
FBXW7 missense mutation: a novel negative prognostic factor in metastatic colorectal adenocarcinoma
Krittiya Korphaisarn et al.
ONCOTARGET (2017)
Increased Frequency of KRAS Mutations in African Americans Compared with Caucasians in Sporadic Colorectal Cancer
Jonas J. Staudacher et al.
CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY (2017)
CDX2 as a Prognostic Biomarker in Stage II and Stage III Colon Cancer
Piero Dalerba et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Prognostic Importance of Cell Cycle Regulators Cyclin D1 (CCND1) and Cyclin-Dependent Kinase Inhibitor 1B (CDKN1B/p27) in Sporadic Gastric Cancers
Petra Minarikova et al.
GASTROENTEROLOGY RESEARCH AND PRACTICE (2016)
A meta-analysis of MSI frequency and race in colorectal cancer
Hassan Ashktorab et al.
ONCOTARGET (2016)
Barriers to Clinical Trial Enrollment in Racial and Ethnic Minority Patients With Cancer
Lauren M. Hamel et al.
CANCER CONTROL (2016)
Molecular pathogenesis of sporadic colorectal cancers
Hidetsugu Yamagishi et al.
CHINESE JOURNAL OF CANCER (2016)
Molecular Biomarkers of Colorectal Cancer and Cancer Disparities: Current Status and Perspective
Upender Manne et al.
CURRENT COLORECTAL CANCER REPORTS (2016)
Molecular markers and pathway analysis of colorectal carcinoma in the Middle East
Shaham Beg et al.
CANCER (2015)
PIK3CA Somatic Mutation Status in Relation to Patient and Tumor Factors in Racial/Ethnic Minorities with Colorectal Cancer
Amanda I. Phipps et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2015)
Racial variation in frequency and phenotypes of APC and MUTYH mutations in 6,169 individuals undergoing genetic testing
Jennifer A. Inra et al.
GENETICS IN MEDICINE (2015)
Racial Differences in BRAF/KRAS Mutation Rates and Survival in Stage III Colon Cancer Patients
Harry H. Yoon et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Increasing Disparities in the Age-Related Incidences of Colon and Rectal Cancers in the United States, 1975-2010
Christina E. Bailey et al.
JAMA SURGERY (2015)
Racial Differences in BRAF/KRAS Mutation Rates and Survival in Stage III Colon Cancer Patients
Harry H. Yoon et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Changes in colorectal cancer incidence rates in young and older adults in the United States: what does it tell us about screening
Harland Austin et al.
CANCER CAUSES & CONTROL (2014)
KRAS gene somatic mutations in Chilean patients with colorectal cancer
Claudia Hurtado et al.
REVISTA MEDICA DE CHILE (2014)
The clinical perspectives of CDX2 expression in colorectal cancer: A qualitative systematic review
J. Olsen et al.
SURGICAL ONCOLOGY-OXFORD (2014)
HER2 gene copy number status may influence clinical efficacy to anti-EGFR monoclonal antibodies in metastatic colorectal cancer patients
V. Martin et al.
BRITISH JOURNAL OF CANCER (2013)
Rare Though Not Mutually Exclusive: A Report of Three Cases of Concomitant KRAS and BRAF Mutation and a Review of the Literature
Ibrahim Halil Sahin et al.
JOURNAL OF CANCER (2013)
K-RAS mutation profile in Puerto Rican patients with colorectal cancer: trends from April 2009 to January 2011
Yelitza Ruiz-Candelaria et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS (2013)
Comprehensive molecular characterization of human colon and rectal cancer
Donna M. Muzny et al.
NATURE (2012)
Colorectal cancer molecular biology moves into clinical practice
Colin C. Pritchard et al.
GUT (2011)
Mismatch repair protein expression and colorectal cancer in Hispanics from Puerto Rico
Wilfredo E. De Jesus-Monge et al.
FAMILIAL CANCER (2010)
Genome-wide patterns of population structure and admixture among Hispanic/Latino populations
Katarzyna Bryc et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Testing the importance of p27 degradation by the SCFskp2 oathwav in murine models of lung and colon cancer
Inke Timmerbeul et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
分享论文
